CIK 0001991792
- Large accelerated filer
CG Oncology, Inc.
Sign in to watch- Ticker
- CGON
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 371611499
- Phone
- +1 949-409-3700
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1640, DALLAS, TX, 75247
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 1,964 shares at an average $63.50 ($124,714)
- 4 Exercise or conversion Chief Executive Officer acquired 64,612 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 102,871 shares (option exercise)
- 4 Planned sale Director sold 11,145 shares at an average $52.47 ($584,799)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 1,000 shares at $41.43 ($41,430)
- 4 Planned sale Director sold 1,000 shares at $43.25 ($43,250)
- 4 Planned sale Director sold 5,903 shares at $43.99 ($259,673)
- 4 Planned sale Director sold 5,000 shares at $40.09 ($200,450)
- 4 Planned sale Director sold 12,755 shares at $39.19 ($499,868)
- 4 Planned sale Director sold 22,686 shares at an average $39.01 ($884,909)
- 4 Planned sale Director sold 1,000 shares at $35.10 ($35,100)
- 4 Open-market buy Director bought 1,515,151 shares at $33.00 ($49,999,983)
- 4 Planned sale Director sold 27,015 shares at an average $31.53 ($851,797)
Page 2 of 5 · 94 filings